Clin2
NCT07007585Likely a fitRecruiting

Dengue care: who needs hospital or transfusion?

DengueDengue FeverDengue Fever With Warning Signs

Part of Blood & lymphatic, Infections clinical trials.

This study looks at why some people with dengue need to be hospitalized or get a blood transfusion. It aims to make care safer and help doctors know who needs closer monitoring.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
5 years and older
Study type
Observational

Who can take part

  • You must be at least 5 years old.
  • You must have dengue confirmed by a lab test (like NS1, IgM, or PCR).
  • This must be your first visit for dengue symptoms — to an emergency room or outpatient clinic.
  • You cannot have COVID-19 or another mosquito-borne virus at the same time.
  • You cannot have a blood disorder or cancer (past or present).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07799168Not yet recruiting
Dengue natural history study for hospitalised patients

This study follows patients hospitalised with dengue to better understand the disease and improve future research. If you are in the hospital with confirmed dengue, you may be eligible to join.

Nha Trang
NCT07203183Not yet recruiting
Dengue blood sample study

This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.

NCT07543458Not yet recruiting· Phase 3
Treatments for moderate and severe dengue

This trial tests new treatments for people hospitalized with moderate to severe dengue, a mosquito-borne illness. It aims to find better ways to reduce symptoms and prevent serious complications.

Chittagong
NCT07409857Recruiting
Dengue infection in congenital bleeding disorders registry

This study creates a registry to track how dengue infection affects people with congenital bleeding disorders, such as hemophilia. It aims to learn more about managing dengue in this group.

Bangkok
NCT04597437Recruiting· Phase 2
Zanamivir for dengue that causes warning signs

This Phase 2 study tests whether zanamivir given through a vein can improve outcomes in people with dengue infection who have warning signs. It may help by reducing the body problems dengue can cause in blood vessels and fluid balance.

Barranquilla, Atlántico
NCT06843226Recruiting
Dengue vaccine study for children and teens

This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.

Banjarmasin, South Kalimantan

Hear when a new Dengue trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.